PBI30 BUDGET-IMPACT AND COST-EFFECTIVENESS OF TILDRAKIZUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS FROM A US HEALTH PLAN PERSPECTIVE
Carrico, J., Jia, X., Zhao, Y., Zhang, J., Brodtkorb, T.H., Mendelsohn, A.B., Lowry, S., Wu, J.J., Feldman, S.R., Armstrong, A.W.
Published in Value in health (01.05.2019)
Published in Value in health (01.05.2019)
Get full text
Journal Article